Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03529214 · ClinicalTrials.gov registry record · NA

An Evaluation of the Team Birth Project

A NA study of Pregnancy Complications and Cesarean Section Complications, sponsored by Harvard School of Public Health (HSPH).

Completed
Registry status
NA
Development phase
5,217
Enrollment target
4
Study locations

NCT03529214 is a NA study of Pregnancy Complications and Cesarean Section Complications that has completed, run by Harvard School of Public Health (HSPH). The registered enrollment target is 5,217 participants, above the 3,657-participant average among 39 other Pregnancy Complications trials with a reported enrollment target (43% higher). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03529214, a NA study of Pregnancy Complications and Cesarean Section Complications, has completed, sponsored by Harvard School of Public Health (HSPH).

COMPLETED
Registry status
NA
Development phase
5,217 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to evaluate the feasibility of a pilot project to improve communication and teamwork and to increase vaginal delivery rates at hospital in the United States

Interventions

  • BEHAVIORAL Exposed study site

Study Locations (4)

Washington

  • Overlake Medical Center - Bellevue
  • EvergreenHealth Medical Center - Kirkland

Massachusetts

  • South Shore Hospital - Weymouth

Oklahoma

  • Saint Francis Hospital - Tulsa

Trial Details

FieldValue
Enrollment Target 5,217 participants
Start Date 2018-05-29
Est. Completion 2019-12-31
Phase NA

What the Registry Record Tells You About NCT03529214

The ClinicalTrials.gov registry entry for NCT03529214 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5,217 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,657-participant average among 39 other Pregnancy Complications trials with a reported enrollment target (43% higher). The listed sponsor is Harvard School of Public Health (HSPH), which has 40 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Pregnancy Complications appearing as the primary indexed condition, and to 1 intervention - of which Exposed study site is the first listed.

NCT03529214 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Washington, Massachusetts, Oklahoma.

Frequently Asked Questions

What is clinical trial NCT03529214 about?

NCT03529214 is a clinical study titled "An Evaluation of the Team Birth Project". The purpose of this study is to evaluate the feasibility of a pilot project to improve communication and teamwork and to increase vaginal delivery rates at hospital in the United States

What is the current status of trial NCT03529214?

This trial is currently completed. It is a NA study. The enrollment target is 5,217 participants. The study started on 2018-05-29. Estimated completion is 2019-12-31.

What conditions does trial NCT03529214 study?

This clinical trial studies the following conditions: Pregnancy Complications, Cesarean Section Complications, Maternal Complication of Pregnancy, Communication, Multidisciplinary.

What interventions are being tested in trial NCT03529214?

The interventions under investigation include: Exposed study site (BEHAVIORAL).

Who is sponsoring clinical trial NCT03529214?

This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03529214 being conducted?

This trial has 4 study locations across Massachusetts, Oklahoma, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy Complications

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.